People were dying of a disease that could be treated — but in poor countries, they did not have access to medicines that could help. That was the story of HIV — and now of COVID-19.
The administration is in its early days, but the infectious disease expert says he's encouraged by the new president's attitude about the pandemic. Science, Fauci says, is "going to rule."
The No. 1 and 2 causes of death remain the same, but there have been a number of notable changes. And now there's a new disease to assess on the global landscape: COVID-19.
The drugs only need to be taken a few times a year — and may soon be available in many parts of the world. Patients say they are more convenient and less stigmatizing.
The coronavirus pandemic feels eerily familiar to people who faced the AIDS crisis. It triggers memories of confusion over how the disease is transmitted and huge numbers of people dying quickly.
New Yorker writer Michael Specter covered Fauci's early work in the AIDS epidemic. "He's always taken an open-minded approach to the problems," Specter says of the infectious-disease expert.
As we find ourselves in the midst of a pandemic, Paul Lisicky's memoir is deeply affecting; we can recall the terror and frustration when no treatment or prevention was available for AIDS and HIV.
Fewer than a third of the 220 counties deemed by the federal government as vulnerable to similar outbreaks have active syringe exchange programs which can stop the spread of the infection.
In more than 30 states, it is illegal for someone with HIV to have sex without first disclosing their status. Some are now trying to change that, arguing that those laws endanger public health.
The topics range from a ticking time bomb in the Arctic to the art of taking selfies in an ethical way. Here are the stories selected by our contributors.
For people at high risk of HIV, taking a daily dose of a prevention drug is essential. But many can't afford it. A new federal program makes the drugs available for free.
Doctors used to worry that antiretroviral drugs were too powerful for HIV-positive newborns. More evidence is emerging that, in fact, early treatment can be safe and effective.
Thrive SS, an HIV support program by and for black men, credits its popularity to its grassroots approach. But the model, which focuses on forming a social networks, misses out on federal funding.
A new documentary tells the story of America's first inpatient unit dedicated to the care of people with AIDS. Nurse Cliff Morrison helped create 5B in 1983, and worked on it with Dr. Paul Volberding.
The U.S. Preventive Services Task Force says people at high risk of being infected with HIV should be offered a daily pill containing antiretroviral medications. The drug's cost remains a hurdle.
In the 1980s, ACT UP demanded action from the U.S. government and got results with drama. AIDS activists today have fresh tactics for their new goal: a more affordable HIV prevention pill.
In late April, a tragedy began to unfold in Larkana. First one, then 15, now hundreds of youngsters have been found to be HIV positive. Who is responsible?
As head of the Department of Health and Human Services, Alex Azar is charged with making Trump's plan to end HIV in the U.S. by 2030 work. "We have an historic opportunity," he tells NPR.
British doctors report the apparent eradication of HIV from a patient who was undergoing treatment for cancer. It's only the second time this has been accomplished, despite many attempts.
